— Know what they know.
Not Investment Advice
Also trades as: 0013.HK (HKSE) · $vol 14M · HCM.L (LSE) · $vol 0M · HMDCF (OTC) · $vol 0M

HCM NASDAQ

HUTCHMED (China) Limited
1W: +1.9% 1M: +17.9% 3M: +21.9% YTD: +4.0% 1Y: -11.0% 3Y: -14.9% 5Y: -61.2%
$14.20
-0.37 (-2.54%)
 
Weekly Expected Move ±6.5%
$12 $13 $14 $15 $16
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 66 · $2.5B mcap · 170M float · 0.039% daily turnover · Short 32% of daily vol

Cash Flow Trends

Operating Cash Flow
-$65M -13143.9% ▼
Capital Expenditures
$14M +20.9% ▲
5Y CAGR: -6.2%
Free Cash Flow
-$79M -353.2% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
-$83M +36.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$167M-$360M$101M$38M$458M
Depreciation & Amort.$7M$9M$8M$12M$13M
Stock-Based Comp.$42M$31M$37M$22M$0
Change in Working Capital$32M$59M$71M-$62M-$61M
Other Non-Cash Items-$4M-$6M$105M-$9M-$475M
Operating Cash Flow-$204M-$269M$219M$497K-$65M
— Investing Activities —
Capital Expenditures-$17M-$37M-$33M-$18M-$24M
Acquisitions (Net)$159M$324K-$3M$0$28K
Investment Purchases-$1.4B-$1.2B-$1.6B-$1.8B-$2.7B
Investment Sales$921M$1.5B$1.4B$1.8B$2.7B
Other Investing$930K$16M$0$1M$0
Investing Cash Flow-$306M$297M-$291M-$96M-$29M
— Financing Activities —
Net Debt Issuance-$580K-$9M$62M$6M$6M
Stock Repurchased-$27M-$48M-$9M-$36M$0
Dividends Paid-$100M-$87M$0$0$0
Other Financing$60M$62M-$9M-$1M$0
Financing Cash Flow$650M-$83M$49M-$31M$8M
Net Change in Cash$142M-$64M-$30M-$130M-$83M
Cash End of Period$378M$313M$284M$154M$71M
Free Cash Flow-$221M-$305M$187M-$17M-$79M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms